Fiera Capital Corp Sells 2,992 Shares of Danaher Corporation $DHR

Fiera Capital Corp decreased its position in Danaher Corporation (NYSE:DHR) by 17.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,964 shares of the conglomerate’s stock after selling 2,992 shares during the quarter. Fiera Capital Corp’s holdings in Danaher were worth $3,197,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in DHR. JPL Wealth Management LLC bought a new position in Danaher in the 3rd quarter valued at $25,000. Elevated Capital Advisors LLC bought a new position in Danaher during the fourth quarter valued at $26,000. WFA of San Diego LLC bought a new position in Danaher during the second quarter valued at $26,000. ANTIPODES PARTNERS Ltd bought a new position in Danaher during the third quarter valued at $27,000. Finally, Financial Life Planners bought a new position in Danaher during the third quarter valued at $32,000. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 2.6%

Shares of DHR stock opened at $188.38 on Wednesday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The business has a 50-day moving average price of $181.33 and a two-hundred day moving average price of $205.56. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a market cap of $133.33 billion, a P/E ratio of 36.44, a price-to-earnings-growth ratio of 2.45 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the firm posted $1.88 earnings per share. The business’s revenue was up 3.7% compared to the same quarter last year. Equities analysts anticipate that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Analysts Set New Price Targets

DHR has been the topic of a number of research reports. Morgan Stanley lowered their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. HSBC cut their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 price objective on shares of Danaher in a research note on Tuesday, April 21st. Barclays decreased their price objective on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Finally, The Goldman Sachs Group reduced their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $235.14.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.